Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100

The role of maintenance therapy for gastric (GC) or gastroesophageal junction cancer (GEJC) is unclear. We investigated avelumab (anti–programmed death ligand-1 [PD-L1]) maintenance after first-line induction chemotherapy for GC/GEJC. PATIENTS AND METHODS: JAVELIN Gastric 100 was a global, open-labe...

Descripción completa

Detalles Bibliográficos
Autores principales: Moehler, Markus, Dvorkin, Mikhail, Boku, Narikazu, Özgüroğlu, Mustafa, Ryu, Min-Hee, Muntean, Alina S., Lonardi, Sara, Nechaeva, Marina, Bragagnoli, Arinilda C., Coşkun, Hasan S., Cubillo Gracian, Antonio, Takano, Toshimi, Wong, Rachel, Safran, Howard, Vaccaro, Gina M., Wainberg, Zev A., Silver, Matthew R., Xiong, Huiling, Hong, Janet, Taieb, Julien, Bang, Yung-Jue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078426/
https://www.ncbi.nlm.nih.gov/pubmed/33197226
http://dx.doi.org/10.1200/JCO.20.00892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078426/
https://www.ncbi.nlm.nih.gov/pubmed/33197226
http://dx.doi.org/10.1200/JCO.20.00892

Ejemplares similares